Xtant Medical Holdings (XTNT) Cash from Operations (QoQ) (2010 - 2025)
Xtant Medical Holdings (XTNT) Cash from Operations (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Xtant Medical Holdings | 5.69 Mn | -11.63 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 261.44% |
| Jun 30, 2025 | -0.16% |
| Mar 31, 2025 | 92.18% |
| Dec 31, 2024 | 138.71% |
| Sep 30, 2024 | 66.23% |
| Jun 30, 2024 | 11.59% |
| Mar 31, 2024 | -528.96% |
| Dec 31, 2023 | 76.13% |
| Sep 30, 2023 | -52.08% |
| Jun 30, 2023 | -12.29% |
| Mar 31, 2023 | 1.88% |
| Dec 31, 2022 | -10.85% |
| Sep 30, 2022 | -13,860.00% |
| Jun 30, 2022 | 101.49% |
| Mar 31, 2022 | -337.35% |
| Dec 31, 2021 | 145.68% |
| Sep 30, 2021 | -141.17% |
| Jun 30, 2021 | 272.07% |
| Mar 31, 2021 | -242.69% |
| Dec 31, 2020 | 1,390.14% |